Impact of Vicryl Plus to prevent infection of leg in the operations of Safena Bypasses.

INTERVENTION: A07.231.908.819 E04.100 E04.100.376.719 E04.987.775 Experimental ‐ Polyglactin suture coated with polyglactin 370 and calcium stearate impregnated with Triclosan (Irgacare MP *), which is (5‐chloro‐2 (2,4‐dichlorophenoxyphenol)). This procedure was applied topically, once in 251 patients Control ‐ Polyglactin yarn coated with polyglactin 370 and calcium stearate. This procedure was applied topically, once in 258 patients Procedure/surgery CONDITION: E04.100 E04.100.376.719 Patients submitted exclusively to Myocardial Revascularization with or without Extracorporeal Circulation ; E04.100 ; E04.100.376.719 PRIMARY OUTCOME: The safenectomy wound infection rate, it is a binary variable (presence or absence) that will be measured by percentage of occurrence SECONDARY OUTCOME: Rate of hyperthermia in saphenectomy wounds evaluated at three visits in the first 30 days after surgery; criterion, with touch with glove of; cold, normal and hot. Rate of pain in the wounds of the saphenectomy; evaluated in three visits in the first thirty days after surgery; criterion; 0 = absence, 1 = mild, 2 = moderate, 3 = severe. INCLUSION CRITERIA: Volunteers with indication of myocardial revascularization, with or without extracorporeal circulation; of both sexes, with age above 30 years